223 related articles for article (PubMed ID: 32361816)
1. The epidemiology of aggressive pituitary tumors (and its challenges).
Dekkers OM; Karavitaki N; Pereira AM
Rev Endocr Metab Disord; 2020 Jun; 21(2):209-212. PubMed ID: 32361816
[TBL] [Abstract][Full Text] [Related]
2. Definition and diagnosis of aggressive pituitary tumors.
Kasuki L; Raverot G
Rev Endocr Metab Disord; 2020 Jun; 21(2):203-208. PubMed ID: 31808044
[TBL] [Abstract][Full Text] [Related]
3. Invasive pituitary adenomas: significance of proliferation parameters.
Amar AP; Hinton DR; Krieger MD; Weiss MH
Pituitary; 1999 Aug; 2(2):117-22. PubMed ID: 11081161
[TBL] [Abstract][Full Text] [Related]
4. Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions.
Trouillas J; Jaffrain-Rea ML; Vasiljevic A; Dekkers O; Popovic V; Wierinckx A; McCormack A; Petersenn S; Burman P; Raverot G; Villa C
Rev Endocr Metab Disord; 2020 Jun; 21(2):243-251. PubMed ID: 32504268
[TBL] [Abstract][Full Text] [Related]
5. Early recognition of aggressive pituitary adenomas: a single-centre experience.
Ceccato F; Regazzo D; Barbot M; Denaro L; Emanuelli E; Borsetto D; Rolma G; Alessio L; Gardiman MP; Lombardi G; Albiger N; D'Avella D; Scaroni C
Acta Neurochir (Wien); 2018 Jan; 160(1):49-55. PubMed ID: 29170844
[TBL] [Abstract][Full Text] [Related]
6. Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas.
Zaidi HA; Cote DJ; Dunn IF; Laws ER
J Clin Neurosci; 2016 Dec; 34():246-251. PubMed ID: 27765563
[TBL] [Abstract][Full Text] [Related]
7. Aggressive Pituitary Adenomas and Carcinomas.
Ilie MD; Jouanneau E; Raverot G
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):505-515. PubMed ID: 32741485
[TBL] [Abstract][Full Text] [Related]
8. How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies.
Dai C; Kang J; Liu X; Yao Y; Wang H; Wang R
Front Endocrinol (Lausanne); 2021; 12():604644. PubMed ID: 33815274
[TBL] [Abstract][Full Text] [Related]
9. The Epidemiology of Pituitary Adenomas.
Daly AF; Beckers A
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):347-355. PubMed ID: 32741475
[TBL] [Abstract][Full Text] [Related]
10. Clinically aggressive phenotype: A clinicopathological case series of atypical pituitary adenomas.
Lv L; Hu Y; Yin S; Wang M; Zhou P; Zhang N; Ma W; Zhang S; Jiang S
Clin Neurol Neurosurg; 2018 Apr; 167():93-98. PubMed ID: 29471288
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas.
Ntali G; Wass JA
Pituitary; 2018 Apr; 21(2):111-118. PubMed ID: 29368293
[TBL] [Abstract][Full Text] [Related]
12. Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas.
Das L; Gupta N; Dutta P; Walia R; Vaiphei K; Rai A; Radotra BD; Gupta K; Sreedharanunni S; Ahuja CK; Bhansali A; Tripathi M; Sood R; Dhandapani S
Front Endocrinol (Lausanne); 2021; 12():774686. PubMed ID: 34975752
[TBL] [Abstract][Full Text] [Related]
13. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology and genetics of pituitary adenomas.
Daly AF; Tichomirowa MA; Beckers A
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):543-54. PubMed ID: 19945022
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of pituitary adenomas: a systematic review.
Ezzat S; Asa SL; Couldwell WT; Barr CE; Dodge WE; Vance ML; McCutcheon IE
Cancer; 2004 Aug; 101(3):613-9. PubMed ID: 15274075
[TBL] [Abstract][Full Text] [Related]
16. Double adenomas of the pituitary: an imaging, pathological, and clinical diagnostic challenge.
Kontogeorgos G; Thodou E
Hormones (Athens); 2019 Sep; 18(3):251-254. PubMed ID: 31388898
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenomas and granular cell tumors. Incidence, cell type, and location of tumor in 100 pituitary glands at autopsy.
Tomita T; Gates E
Am J Clin Pathol; 1999 Jun; 111(6):817-25. PubMed ID: 10361519
[TBL] [Abstract][Full Text] [Related]
18. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors.
Nishioka H; Inoshita N
Brain Tumor Pathol; 2018 Apr; 35(2):57-61. PubMed ID: 29318396
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenoma: a radiotherapeutic perspective.
Platta CS; Mackay C; Welsh JS
Am J Clin Oncol; 2010 Aug; 33(4):408-19. PubMed ID: 19687730
[TBL] [Abstract][Full Text] [Related]
20. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]